Novel approaches for prevention of stroke related to transcatheter aortic valve implantation

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 10, 2013, Pages 1311-1320

  Ghanem, Alexander ^a   Kocurek, Justine ^a   Sinning, Jan Malte ^a   Weber, Marcel ^a   Hammerstingl, Christoph ^a   Wagner, Michael ^a,b   Vasa Nicotera, Mariuca ^a   Grube, Eberhard ^a   Werner, Nikos ^a   Nickenig, Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Aortic stenosis; Aspirin; Clopidogrel; Dementia; DW MRI; Embolism; Filter; Stroke; TIA; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN;

AORTA VALVE STENOSIS; ARTIFICIAL EMBOLISM; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; COMORBIDITY; EMBOLIC PROTECTION DEVICE; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; PATIENT SELECTION; PROGNOSIS; REVIEW; RISK FACTOR; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR ACCESS;

ANESTHESIA, GENERAL; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION; PROGNOSIS; RESPIRATION, ARTIFICIAL; STROKE;

EID: 84886620841     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2013.837696     Document Type: Review

References (60)

1. Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363 (17), 1597-1607 (2010).
2. Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364 (23), 2187-2198 (2011).
3. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics - update: A report from the American Heart Association. Circulation 125 (1), e2-e220 (2012).
4. Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. J. Am. Coll. Cardiol. 57 (3), 17-17 (2011).
5. Brott T, Adams HP, Olinger CP et al. Measurements of acute cerebral infarction: A clinical examination scale. Stroke 20 (7), 864-870 (1989).
6. Kappetein AP, Head SJ, Généreux P et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. Eur. Heart J. 33 (19), 2403-2418 (2012).
7. Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366 (18), 1696-1704 (2012).
8. Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366 (18), 1686-1695 (2012).
9. Khatri PJ, Webb JG, Rodés-Cabau J et al. Adverse effects associated with transcatheter aortic valve implantation: A meta-Analysis of contemporary studies. Ann. Intern. Med. 158 (1), 35-46 (2012).
10. Eggebrecht H, Schmermund A, Voigtländer T et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): A meta-Analysis of 10,037 published patients. EuroIntervention 8 (1), 129-138 (2012).
11. Nuis R-J, Van Mieghem NM, Schultz CJ et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am. J. Cardiol. 109 (11), 1637-1643 (2012).
12. Tay EL, Gurvitch R, Wijesinghe N et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 4 (12), 1290-1297 (2011).
13. Nombela-Franco L, Webb JG, de Jaegere PP et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126 (25), 3041-3053 (2012).
14. Fairbairn TA, Mather AN, Bijsterveld P et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: Assessment of predictive risk factors and the relationship to subsequent health status. Heart 98 (1), 18-23 (2011).
15. Omran H, Schmidt H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: A prospective, randomised study. Lancet 361 (9365), 1241-1246 (2003).
16. Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: A diffusion-weighted magnetic resonance imaging study. Circulation 121 (7), 870-878 (2010).
17. Ghanem A, Müller A, Nähle CP et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: A prospective pilot study with diffusion-weighted magnetic resonance imaging. J. Am. Coll. Cardiol. 55 (14), 1427-1432 (2010).
18. Rodés-Cabau J, Dumont E, Boone RH et al. Cerebral embolism following transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 57 (1), 18-28 (2011).
19. Kahlert P, Al-Rashid F, Döttger P et al. Cerebral embolization during transcatheter aortic valve implantation: A transcranial Doppler study. Circulation 126 (10), 1245-1255 (2012).
20. Erdoes G, Basciani R, Huber C et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 41 (4), 778-774 (2012).
21. Kaireviciute D, Aidietis A, Lip GY. Atrial fibrillation following cardiac surgery: Clinical features and preventative strategies. Eur. Heart J. 30 (4), 410-425 (2009).
22. Almassi GH, Schowalter T, Nicolosi AC et al. Atrial fibrillation after cardiac surgery: A major morbid event? Ann. Surg. 226 (4), 501-511 (1997).
23. Amat-Santos IJ, Rodés-Cabau J, Urena M et al. Incidence, Predictive Factors, and Prognostic Value of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation. J. Am. Coll. Cardiol. 59 (2), 178-188 (2012).
24. Adam N, Kandelman S, Mantz J, Chrétien F, Sharshar T. Sepsis-induced brain dysfunction. Expert Rev. Anti Infect. Ther. 11 (2), 211-221 (2013).
25. Knipp SC, Kahlert P, Jokisch D et al. Cognitive function after transapical aortic valve implantation: A single-centre study with 3-month follow-up. Interact. Cardiovasc. Thorac. Surg. 16 (2), 116-122 (2013).
26. Ghanem A, Müller A, Sinning J-M et al. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention 8 (11), 1294-1306 (2013).
27. Georgiadou P, Sbarouni E, Karavolias GK, Voudris V. Transcatheter aortic valve implantation: Restoring the qualities of life in old age. Age Ageing 42 (1), 21-26 (2012).
28. Reynolds MR, Magnuson EA, Lei Y, Leon MB. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosisclinical perspective. Circulation 124 (18) 1964-1972 (2011).
29. Reynolds MR, Magnuson EA, Wang K et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J. Am. Coll. Cardiol. 60 (6), 548-558 (2012).
30. Stortecky S, Schmid V, Windecker S et al. Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation. EuroIntervention 8 (4), 437-443 (2012).
31. Fairbairn TA, Meads DM, Mather AN et al. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: Predictors of health outcomes. J. Am. Coll. Cardiol. 59 (19), 1672-1680 (2012).
32. Knipp SC, Matatko N, Schlamann M et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: Relation to neurocognitive function. Eur. J. Cardiothorac. Surg. 28 (1), 88-96 (2005).
33. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: A systematic review. Lancet Neurol. 6 (7), 611-619 (2007).
34. Böttiger BW, Möbes S, Glätzer R et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 103 (22), 2694-2698 (2001).
35. Oh SH, Lee JG, Na SJ, Park JH, Choi YC, Kim WJ. Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level. Arch. Neurol. 60 (1), 37-41 (2002).
36. Ramont L, Thoannes H, Volondat A, Chastang F, Millet MC, Maquart FX. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: Implications in clinical practice. Clin. Chem. Lab. Med. 43 (11), 1215-1217 (2005).
37. Reinsfelt B, Westerlind A, Ioanes D, Zetterberg H, Fredén- Lindqvist J, Ricksten SE. Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol. Scand. 56 (2), 240-247 (2012).
38. Patti G, Tomai F, Melfi R et al. Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting: Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study. J. Am. Coll. Cardiol. 61 (13), 1379-1387 (2013).
39. Stortecky S, Windecker S. Stroke an infrequent but devastating complication in cardiovascular interventions. Circulation 126 (25), 2921-2924 (2012).
40. Bagur R, Rodés-Cabau J, Doyle D. Transcatheter aortic valve implantation with " no touch" of the aortic arch for the treatment of severe aortic stenosis associated with complex aortic atherosclerosis. J. Card. Surg. 25 (5), 501-503 (2010).
41. Grube E, Naber C, Abizaid A. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: A pilot study. JACC Cardiovasc. Interv. 4 (7), 751-757 (2011).
42. Garg N, Karagiorgos N, Pisimisis GT, Sohal D. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: A systematic review of the current literature. J. Endovasc. Ther. 16 (2), 412-427 (2009).
43. Onsea K, Agostoni P, Samim M et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 8 (1), 51-56 (2012).
44. Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv. 3 (11), 1133-1138 (2010).
45. Naber CK, Ghanem A, Abizaid AA et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8 (1), 43-50 (2012).
46. Van Mieghem NM, Schipper ME, Ladich E et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 127 (22), 2194-2201 (2013).
47. Wann LS, Curtis AB, January CT et al. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practise Guidelines. J. Am. Coll. Cardiol. 57 (2), 223-242 (2011).
48. Mitchell LB, CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention and treatment of atrial fibrillation following cardiac surgery. Can. J. Cardiol. 27 (1), 91-97 (2011).
49. Healey JS, Connolly SJ, Gold MR et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N. Engl. J. Med. 366, 120-129 (2012).
50. Gherli T, Colli A, Fragnito C et al. Comparing warfarin with aspirin after biological aortic valve replacement: A prospective study. Circulation 110 (5), 496-500 (2004).
51. Mistiaen W, Van Cauwelaert P, Muylaert P, Sys SU, Harrisson F, Bortier H. Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis. J. Thorac. Cardiovasc. Surg. 127 (4), 1166-1170 (2004).
52. Toni D, Fiorelli M, Bastianello S et al. Hemorrhagic transformation of brain infarct: Predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 46 (2), 341-345 (1996).
53. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 48 (3), e1-e148 (2006).
54. Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012). Eur. Heart J. 33 (19), 2451-2496 (2012).
55. Mérie C, Køber L, Skov Olsen P et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA 308 (20), 2118-2125 (2012).
56. Lange R, Bleiziffer S, Mazzitelli D et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients. J. Am. Coll. Cardiol. 59 (3), 280-287 (2012).
57. Wenaweser P, Stortecky S, Schwander S et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur. Heart J. 34 (25), 1894-1905 (2013).
58. Dewilde WJ, Oirbans T, Verheugt FW et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial. Lancet 381 (9872), 1107-1115 (2013)
59. Dans AL, Connolly SJ, Wallentin L et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation 127 (5), 634-640 (2013)
60. Sinning JM, Hammerstingl C, Vasa-Nicotera M et al. Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection. EuroIntervention 8 (5), 640-641 (2012).